Pembrolizumab and Gemcitabine Chemotherapy in Leiomyosarcoma and Undifferentiated Pleomorphic Sarcoma
Clinical trial NCT03123276 · COMPLETED
Trial details
- NCT number
- NCT03123276
- Sponsor
- Royal Marsden NHS Foundation Trust
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-29
- Primary completion
- 2022-05-20
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.